Compare CLS & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLS | IDXX |
|---|---|---|
| Founded | 1994 | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9B | 45.4B |
| IPO Year | 1999 | 1996 |
| Metric | CLS | IDXX |
|---|---|---|
| Price | $356.53 | $529.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 9 |
| Target Price | $404.13 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 2.0M | 433.8K |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.34 | 22.59 |
| EPS | 5.01 | ★ 7.74 |
| Revenue | ★ $12,390,900,000.00 | $4,303,702,000.00 |
| Revenue This Year | $41.81 | $10.88 |
| Revenue Next Year | $39.95 | $8.59 |
| P/E Ratio | $72.91 | ★ $66.97 |
| Revenue Growth | ★ 28.46 | 10.42 |
| 52 Week Low | $230.24 | $500.61 |
| 52 Week High | $474.03 | $769.98 |
| Indicator | CLS | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 57.90 | 48.69 |
| Support Level | $336.33 | $520.96 |
| Resistance Level | $368.68 | $581.28 |
| Average True Range (ATR) | 17.18 | 11.38 |
| MACD | 4.90 | 2.36 |
| Stochastic Oscillator | 65.04 | 94.12 |
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.